IntelliPharmaCeutics International (TSXV:IPCI) EV-to-EBITDA : -1.40 (As of May. 21, 2024)

IntelliPharmaCeutics International EV-to-EBITDA Chart

IntelliPharmaCeutics International Annual Data
	Trend	Nov13	Nov14	Nov15	Nov16	Nov17	Nov18	Nov19	Nov20	Nov21	Nov22
EV-to-EBITDA		Get a 7-Day Free Trial					-0.11	-0.71	-2.44	-1.12	-1.97

IntelliPharmaCeutics International Quarterly Data
	Nov18	Feb19	May19	Aug19	Nov19	Feb20	May20	Aug20	Nov20	Feb21	May21	Aug21	Nov21	Feb22	May22	Aug22	Nov22	Feb23	May23	Aug23
EV-to-EBITDA	Get a 7-Day Free Trial															-1.43	-1.97	-2.16	-3.39	-1.53

Competitive Comparison of IntelliPharmaCeutics International's EV-to-EBITDA

For the Biotechnology subindustry, IntelliPharmaCeutics International's EV-to-EBITDA, along with its competitors' market caps and EV-to-EBITDA data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

IntelliPharmaCeutics International's EV-to-EBITDA Distribution in the Biotechnology Industry

For the Biotechnology industry and Healthcare sector, IntelliPharmaCeutics International's EV-to-EBITDA distribution charts can be found below:

* The bar in red indicates where IntelliPharmaCeutics International's EV-to-EBITDA falls into.

IntelliPharmaCeutics International EV-to-EBITDA Calculation

IntelliPharmaCeutics International's EV-to-EBITDA for today is calculated as:

IntelliPharmaCeutics International's current Enterprise Value is C$5.12 Mil.
IntelliPharmaCeutics International's EBITDA for the trailing twelve months (TTM) ended in Aug. 2023 adds up the quarterly data reported by the company within the most recent 12 months, which was C$-3.65 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

IntelliPharmaCeutics International  (TSXV:IPCI) EV-to-EBITDA Explanation

EV-to-EBITDA is a valuation multiple used in finance and investment to measure the value of a company. This important multiple is often used in conjunction with, or as an alternative to, the PE Ratio to determine the fair market value of a company.

IntelliPharmaCeutics International's PE Ratio for today is calculated as:

IntelliPharmaCeutics International's share price for today is C$0.08.
IntelliPharmaCeutics International's Earnings per Share (Diluted) for the trailing twelve months (TTM) ended in Aug. 2023 adds up the quarterly data reported by the company within the most recent 12 months, which was C$-0.124.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Study has found that the companies with the lowest EV-to-EBITDA outperforms companies measured as cheap by other ratios such as PE Ratio.

Please read Which price ratio outperforms the enterprise multiple?

IntelliPharmaCeutics International EV-to-EBITDA Related Terms

Thank you for viewing the detailed overview of IntelliPharmaCeutics International's EV-to-EBITDA provided by GuruFocus.com. Please click on the following links to see related term pages.

IntelliPharmaCeutics International (TSXV:IPCI) Business Description